Heavy metal content determination is a core chemical safety test for medical plastics used in infusion devices, syringes, catheters, and pharmaceutical packaging. Trace elements such as lead, cadmium, mercury, and hexavalent chromium can migrate from polymers, pigments, and heat stabilizers into patients or drug products, making analytical verification essential for regulatory compliance. This article reviews the applicable standards, target elements, sample types, and instrumental methods, including ICP-MS, ICP-OES, AAS, and colorimetric limit testing, used by accredited third-party laboratories to determine heavy metals in medical plastic materials.
Technical Overview
Medical plastics, including PVC, polypropylene, polyethylene, polyurethane, polycarbonate, silicone elastomers, and thermoplastic elastomers, may contain heavy metals originating from polymerization catalyst residues, inorganic pigments and colorants, heat and light stabilizers, inorganic fillers, lubricants, and processing equipment contamination. Because these materials frequently contact blood, tissue, infusion fluids, or drug preparations, elemental impurities can migrate into the patient exposure pathway and present toxicological risk.
Heavy metal determination for medical plastics is therefore a fundamental component of chemical safety evaluation. The principal regulatory and pharmacopoeial frameworks include the ISO 10993 series for biological evaluation of medical devices, in particular ISO 10993-1 (evaluation within a risk management process), ISO 10993-17 (establishment of allowable limits for leachable substances), and ISO 10993-18 (chemical characterization of materials). In China, the corresponding standards are the GB/T 16886 series, together with GB/T 14233.1 for chemical analysis of infusion, transfusion, and injection equipment. Pharmaceutical packaging is additionally governed by YBB monographs, USP general chapters such as USP <661.1>, USP <661.2>, USP <232>, and USP <233>, and the ICH Q3D guideline for elemental impurities. Where relevant, EU Directive 94/62/EC on packaging and packaging waste (sum of Pb, Cd, Hg, and Cr(VI) not exceeding 100 mg/kg) and RoHS thresholds (0.1% for Pb, Hg, and Cr(VI); 0.01% for Cd) provide familiar total-content benchmarks.
Testing philosophy distinguishes between total heavy metal content, which measures the entire elemental burden of the material after complete digestion, and extractable or leachable content, which measures the fraction released into simulated-use media such as water or saline. Both approaches are complementary: total content supports material specification and supplier control, while extractable data directly feed the toxicological risk assessment.
Testing Samples
Raw Materials and Additives
Polymer resins in pellet or powder form, masterbatches, inorganic and organic pigments, heat stabilizers, and other additives are tested to verify incoming material quality and to qualify suppliers. Total content analysis of raw materials is the most effective way to control heavy metals before they enter the production chain.
Finished and Semi-Finished Medical Devices
Representative test articles include disposable syringes, infusion and transfusion sets, catheters and tubing, luer connectors, three-way stopcocks, in-line filters, membrane oxygenator housings, respiratory circuit components, and plastic parts of surgical instruments. Both total content and extraction-based testing can be performed on finished devices, with extraction geometry defined according to ISO 10993-12 or GB/T 14233.1.
Pharmaceutical and Medical Packaging
Blister films, rigid bottles, flexible infusion bags, blood collection and storage containers, closures, liners, and composite laminates are tested against pharmacopoeial and national packaging monographs. Blood and blood-component containers are additionally assessed with reference to ISO 3826-1 requirements for extractable substances.
Special and Investigative Samples
Colored or discolored components, parts suspected of contamination, recycled-content verification samples, stability and aging study specimens, and benchmark samples from alternative suppliers or material grades are also routinely submitted for elemental screening and confirmatory analysis.
Testing Items
Test panels are configured according to the applicable standard, the intended use of the device, and the risk classification of the patient contact route. Common panels include the following:
- Regulatory heavy metals: lead (Pb), cadmium (Cd), mercury (Hg), total chromium (Cr), arsenic (As), antimony (Sb), barium (Ba), and selenium (Se)
- Extended elemental impurity panels per ISO 10993-18 and ICH Q3D: nickel, cobalt, copper, zinc, tin, aluminum, vanadium, thallium, molybdenum, manganese, silver, lithium, and other elements relevant to the material formulation
- Speciated analysis: hexavalent chromium (Cr(VI)) and organotin compounds, which carry significantly higher toxicological concern than their elemental counterparts
- Colorimetric limit testing: "heavy metals as lead" as a combined sulfide-precipitable metals parameter per GB/T 14233.1 and YBB monograph methods
- Total content, reported in mg/kg of material, and extractable content, reported in µg/mL or mg/L of the extraction medium
Testing Methods
Sample Preparation and Digestion
For total content determination, specimens are cut or cryo-ground to small pieces, and a weighed portion (typically 0.1 to 0.5 g) is digested by microwave-assisted acid digestion using nitric acid with hydrogen peroxide under controlled temperature and pressure programs, ensuring complete matrix decomposition while preventing volatile losses of mercury and arsenic. Dry ashing at 450 to 550 °C followed by acid dissolution and hot-plate wet digestion remain accepted alternatives for heat-stable elements. For extractable content, samples are contacted with purified water, saline, or a simulated-use fluid at 37 °C under a defined surface-area-to-volume ratio and contact time, following the sample preparation principles of ISO 10993-12 and the procedures described in GB/T 14233.1.
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES)
ICP-OES is the workhorse for multi-element total content analysis. It offers simultaneous quantification of more than twenty elements across mg/kg to low µg/g levels, high matrix tolerance for digested polymer solutions, wide linear dynamic range, and robust day-to-day reproducibility, making it well suited to routine quality control and batch release testing.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
ICP-MS provides ultra-trace multi-element capability with detection limits at the ng/L level in solution, corresponding to sub-µg/kg levels in the original solid. Collision and reaction cell technology removes polyatomic interferences such as argium chloride on arsenic and selenium. ICP-MS is the preferred technique for full chemical characterization under ISO 10993-18, elemental impurity assessment aligned with USP <233> and ICH Q3D, and any application requiring the lowest achievable detection limits.
Atomic Absorption Spectrometry (AAS)
Flame AAS serves higher concentration determinations, graphite furnace AAS achieves trace-level quantification of elements such as cadmium and lead, cold vapor AAS is specific and highly sensitive for mercury, and hydride generation AAS enhances detection of arsenic, selenium, and antimony. AAS remains a cost-effective and standard-compliant option for targeted single-element verification.
Colorimetric Heavy Metals Limit Test
The classical thioacetamide or sulfide colorimetric method compares the brown color produced by the test solution against a lead standard, expressing the result as "heavy metals as lead." This limit test, prescribed by GB/T 14233.1 and YBB monographs, is rapid, inexpensive, and widely used for routine batch screening of infusion equipment and pharmaceutical packaging.
X-ray Fluorescence (XRF) Screening
Non-destructive energy-dispersive XRF provides rapid screening of Pb, Cd, Cr, Hg, and other mid-to-high atomic number elements directly on parts or pellets. Positive or borderline screens are then confirmed by digestion-based quantitative methods.
Speciation and Hyphenated Techniques
Hexavalent chromium is determined by alkaline extraction followed by the 1,5-diphenylcarbazide colorimetric method or by ion chromatography coupled with ICP-MS. Organotin species are quantified by gas chromatography coupled with ICP-MS or MS detection. These techniques distinguish the most toxic chemical forms from total elemental content.
Quality Assurance and Data Integrity
Methods are validated for linearity, accuracy, precision, and detection and quantification limits. Each analytical batch includes reagent blanks, calibration verification standards, duplicate digestions, matrix spikes with acceptance criteria typically of 80 to 120 percent recovery, and certified reference materials such as polyethylene-based elemental CRMs where available. Full reports present results against the applicable limits with documented method, preparation conditions, and measurement uncertainty.
Data Evaluation and Acceptance Criteria
Extractable heavy metal concentrations are compared with allowable limits derived through the toxicological route described in ISO 10993-17, in which tolerable intake values are converted to tolerable exposure levels for the device and a margin of safety of at least one is demonstrated. Total content results are assessed against material specifications, pharmacopoeial monographs such as USP <661.2> extractable element limits, product standards under the GB/T 14233.1 and GB/T 16886 frameworks, and the packaging and RoHS thresholds where those directives apply. Colorimetric results are evaluated as pass or fail against the prescribed lead comparison standard. When a measured element exceeds a screening threshold, the laboratory or toxicologist confirms the finding with a definitive technique and evaluates the patient dose relative to established permissible daily exposure values.
Applications
- Regulatory registration dossiers requiring chemical characterization and biological evaluation reports for medical devices
- Incoming resin, masterbatch, and pigment control, including screening to eliminate cadmium-based pigments and lead chromate colorants from medical plastic formulations
- Pharmaceutical packaging qualification against YBB, USP, and ICH Q3D elemental impurity expectations
- Supplier change control and material substitution studies when introducing new resin grades, recycled content, or alternative colorants
- Stability, aging, and simulated-use studies quantifying element release over the product shelf life
- Failure analysis and contamination investigations for discolored, stained, or out-of-specification components
- Market surveillance and benchmark testing of competitive or replacement products
FAQ
What is the difference between total content and extractable content?
Total content measures all heavy metals present in the plastic after complete acid digestion and is expressed in mg/kg of material. Extractable content measures only the fraction released into water, saline, or another simulated-use medium under defined temperature and contact conditions and is the value directly used in toxicological risk assessment for patient exposure.
Which analytical technique should be selected?
ICP-MS is recommended when the lowest detection limits and broadest elemental coverage are required, such as for ISO 10993-18 characterization. ICP-OES is well suited to routine multi-element total content control, AAS variants are ideal for targeted elements such as mercury, and the colorimetric limit test is economical for routine batch screening per GB/T 14233.1 and YBB monographs.
How much sample is required for testing?
For digestion-based total content analysis, approximately 2 to 5 g of material is typically sufficient. Extraction-based testing generally requires a surface area corresponding to a defined volume of extraction medium, and finished devices may be tested intact by filling the fluid path. Exact quantities depend on the selected standard and device geometry.
What detection limits can be achieved?
ICP-MS routinely achieves sub-µg/kg detection limits for most elements in the solid material, ICP-OES typically operates in the range of 0.01 to 1 mg/kg, graphite furnace AAS and cold vapor AAS reach low µg/kg levels for lead, cadmium, and mercury, and the colorimetric limit test detects down to approximately 1 µg/mL in the test solution, depending on the matrix.
Are heavy metals deliberately added to medical plastics?
Modern medical-grade formulations avoid regulated heavy metal additives, but residues can still originate from polymerization catalysts, inorganic pigments, contaminated fillers, recycled feedstock, and processing equipment. This is why verification testing remains necessary even for certified medical-grade resins.
How are test results judged for safety?
Extractable concentrations are converted into patient doses and compared with tolerable exposure values established under ISO 10993-17, with a margin of safety of at least one indicating acceptable risk. Total content results are compared with the specific product, packaging, or regulatory thresholds applicable to the material.
How long does the testing process take?
Standard turnaround for elemental analysis of medical plastics is typically five to ten working days from receipt of samples, depending on the scope of the panel, the digestion or extraction scheme required, and whether confirmatory speciation testing is triggered by initial findings.